Scientific Sessions 2025  /  Shifting Paradigms in Lipid Management for ASCVD Risk  /  Addressing Triglycerides for CVD Risk: New Approaches, Different Results?
Logo

American Heart Association

  43
  0

Final ID:

Addressing Triglycerides for CVD Risk: New Approaches, Different Results?

  • Orringer, Carl  ( NCH , Naples , Florida , United States )
    • Author Disclosures:
    Carl Orringer: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Shifting Paradigms in Lipid Management for ASCVD Risk

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
CORALreef Lipids Discussant

Lloyd-jones Donald

Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial

Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa

More abstracts from these authors:
Blood Pressure Trajectory and Treatment Patterns Among Older Patients with Apparent Treatment Resistant Hypertension: Insights from a Large, Community-Based Healthcare System

Mamprejew Nicole, Abusulb Ammar, Cubeddu Robert, Kassar Emily, Labovitz Arthur, Orringer Carl, Alvi Mohammed Ali, Albaghdadi Mazen

You have to be authorized to contact abstract author. Please, Login
Not Available